Novel Preventive Approach Against Filgrastim-Induced Bone Pain in Cancer Patients

Clinical trial NCT06265077 · COMPLETED

Trial details

NCT number: NCT06265077
Sponsor: Noha Mansour
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer Filgrastim Adverse Reaction

Start date: 2024-02-01
Primary completion: 2024-10-17
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.